These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22012048)

  • 1. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.
    Danilovic DL; Mendes-Correa MC; Chammas MC; Zambrini H; Marui S
    Clinics (Sao Paulo); 2011; 66(10):1757-63. PubMed ID: 22012048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
    Serranti D; Indolfi G; Nebbia G; Cananzi M; D'Antiga L; Ricci S; Stagi S; Azzari C; Resti M;
    Pediatr Infect Dis J; 2018 Apr; 37(4):287-291. PubMed ID: 28953189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined interferon alpha and ribavirin therapy on thyroid functions in patients with chronic hepatitis C.
    Nadeem A; Aslam M; Khan DA; Hussain T; Khan SA
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):86-9. PubMed ID: 19208310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.
    Krupińska J; Wawrzynowicz-Syczewska M; Urbanowicz W; Pobłocki J; Syrenicz A
    Endokrynol Pol; 2011; 62(6):517-22. PubMed ID: 22144218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism.
    Carella C; Mazziotti G; Morisco F; Rotondi M; Cioffi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
    Eur J Endocrinol; 2002 Jun; 146(6):743-9. PubMed ID: 12039693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study.
    Bini EJ; Mehandru S
    Arch Intern Med; 2004 Nov; 164(21):2371-6. PubMed ID: 15557418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-induced thyroiditis during treatment of chronic hepatitis C.
    Kozielewicz D; Halota W
    Endokrynol Pol; 2012; 63(1):66-70. PubMed ID: 22378101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid dysfunction during interferon alpha therapy for chronic hepatitis C.
    Shen L; Bui C; Mansberg R; Nguyen D; Alam-Fotias S
    Clin Nucl Med; 2005 Aug; 30(8):546-7. PubMed ID: 16024950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin--a review.
    Andrade LJ; Atta AM; D'Almeida Junior A; Paraná R
    Braz J Infect Dis; 2008 Apr; 12(2):144-8. PubMed ID: 18641852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
    Abellán Galiana P; Pérez-Lázaro A; Aguilera Sancho-Tello V; Merino Torres JF; Berenguer Haym M; Piñón Sellés F
    Endocrinol Nutr; 2009 Mar; 56(3):136-9. PubMed ID: 19627727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
    Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of interferon-alpha2b-induced thyroiditis and its exclusivity in a cohort of patients with chronic hepatitis C infection.
    Tran HA; Reeves GE; Jones TL
    QJM; 2009 Feb; 102(2):117-22. PubMed ID: 19033352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peginterferon Lambda-1a Is Associated with a Low Incidence of Autoimmune Thyroid Disease in Chronic Hepatitis C.
    Fredlund P; Hillson J; Gray T; Shemanski L; Dimitrova D; Srinivasan S
    J Interferon Cytokine Res; 2015 Nov; 35(11):841-3. PubMed ID: 26376344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
    Lee YN; Jeong SW; Lim JH; Ryu YS; Jeon SR; Kim SK; Jang JY; Kim YS; Kim BS; Roh MO
    Korean J Hepatol; 2010 Jun; 16(2):187-91. PubMed ID: 20606504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction].
    Obołończyk L; Obołończyk L; Siekierska-Hellmann M; Sworczak K
    Postepy Hig Med Dosw (Online); 2007 Jun; 62():309-21. PubMed ID: 18583950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.
    Obołończyk Ł; Siekierska-Hellmann M; Wiśniewski P; Lewczuk A; Berendt-Obołończyk M; Lakomy A; Michalska Z; Radowska D; Moszkowska G; Bianek-Bodzak A; Sworczak K
    Postepy Hig Med Dosw (Online); 2017 Sep; 71(0):842-849. PubMed ID: 29039351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.
    Gill G; Bajwa H; Strouhal P; Buch HN
    J Med Case Rep; 2016 Sep; 10(1):253. PubMed ID: 27632981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid disease in HCV carriers undergoing antiviral therapy with interferon plus ribavirin.
    Paraná R; Cruz M; Santos-Jesus R; Ferreira K; Codes L; Cruz T
    Braz J Infect Dis; 2000 Dec; 4(6):284-90. PubMed ID: 11136525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective.
    Tran HA; Jones TL; Ianna EA; Foy A; Reeves GE
    Endocr Pract; 2013; 19(2):292-300. PubMed ID: 23186968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.